Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
vancomycin (antibiotic)[CFS] - Enterococcus camelliae |
👶
Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002). Annals of clinical microbiology and antimicrobials (Ann Clin Microbiol Antimicrob ) Vol: 3 Issue Pages: 14 Pub: 2004 Jul 29 Epub: 2004 Jul 29 Authors Jones ME , Draghi DC , Thornsberry C , Karlowsky JA , Sahm DF , Wenzel RP , Html Article Publication |
vancomycin (antibiotic)[CFS] - Enterococcus camelliae |
👶
Antimicrobial Resistance Pattern in Enterococcus faecalis Strains Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial Prostatitis. Korean journal of urology (Korean J Urol ) Vol: 54 Issue 7 Pages: 477-81 Pub: 2013 Jul Epub: 2013 Jul 15 Authors Seo Y , Lee G , Html Article Publication |
vancomycin (antibiotic)[CFS] - Enterococcus camelliae |
👶
Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infection and immunity (Infect Immun ) Vol: 76 Issue 10 Pages: 4726-36 Pub: 2008 Oct Epub: 2008 Aug 4 Authors Sekirov I , Tam NM , Jogova M , Robertson ML , Li Y , Lupp C , Finlay BB , Html Article Publication |
vancomycin (antibiotic)[CFS] - Enterococcus camelliae |
👶
A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiology (Reading, England) (Microbiology ) Vol: 156 Issue Pt 11 Pages: 3354-9 Pub: 2010 Nov Epub: 2010 Aug 19 Authors Tannock GW , Munro K , Taylor C , Lawley B , Young W , Byrne B , Emery J , Louie T , Publication |
vancomycin (antibiotic)[CFS] - Enterococcus camelliae |
👶
[Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016]. Sheng wu gong cheng xue bao = Chinese journal of biotechnology (Sheng Wu Gong Cheng Xue Bao ) Vol: 34 Issue 8 Pages: 1205-1217 Pub: 2018 Aug 25 Epub: Authors Wang X , Zhao C , Li H , Chen H , Jin L , Wang Z , Liao K , Zeng J , Xu X , Jin Y , Su D , Liu W , Hu Z , Cao B , Chu Y , Zhang R , Luo Y , Hu B , Wang H , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.